Literature DB >> 7275727

Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy.

B Fertil, E P Malaise.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7275727     DOI： 10.1016/0360-3016(81)90377-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  66 in total

1.  Differential proliferation dependence of alpha and beta damage in X-irradiated Chinese hamster cells.

Authors:  D Bartkowiak; W Nothdurft; E M Röttinger
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

Review 2.  Exploring two two-edged swords.

Authors:  David J Brenner
Journal:  Radiat Res       Date:  2012-06-27       Impact factor: 2.841

3.  Criteria and techniques for analysing cell survival data.

Authors:  D Bettega; P Calzolari; A Ottolenghi; L Tallone Lombardi
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

Review 4.  Less well known parameters of in vitro radiosensitivity.

Authors:  S Vijayakumar; T C Ng; I Koumoundouros; P D Higgins; F J Thomas
Journal:  J Natl Med Assoc       Date:  1989-07       Impact factor: 1.798

Review 5.  Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection.

Authors:  Michel H Bourguignon; Pablo A Gisone; Maria R Perez; Severino Michelin; Diana Dubner; Marina Di Giorgio; Edgardo D Carosella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

6.  Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers.

Authors:  Qi Liu; Meng Wang; Ashley M Kern; Saman Khaled; Jing Han; Beow Y Yeap; Theodore S Hong; Jeff Settleman; Cyril H Benes; Kathryn D Held; Jason A Efstathiou; Henning Willers
Journal:  Mol Cancer Res       Date:  2015-02-09       Impact factor: 5.852

7.  Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.

Authors:  Athanassios Argiris; Austin G Duffy; Shivaani Kummar; Nicole L Simone; Yoshio Arai; Seungwon W Kim; Susan F Rudy; Vishnu R Kannabiran; Xinping Yang; Minyoung Jang; Zhong Chen; Nanette Suksta; Theresa Cooley-Zgela; Susmita G Ramanand; Aarif Ahsan; Mukesh K Nyati; John J Wright; Carter Van Waes
Journal:  Clin Cancer Res       Date:  2011-07-12       Impact factor: 12.531

8.  Role of transfection and clonal selection in mediating radioresistance.

Authors:  F S Pardo; R G Bristow; A Taghian; A Ong; C Borek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

9.  A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe.

Authors:  Oliver Riesterer; Fumihiko Matsumoto; Li Wang; Jessica Pickett; David Molkentine; Uma Giri; Luka Milas; Uma Raju
Journal:  Invest New Drugs       Date:  2009-12-22       Impact factor: 3.850

10.  Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.

Authors:  T Efferth; U Fabry; P Glatte; R Osieka
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.